Our present findings indicate that WJ-39 inhibited the activity of AR and effectively ameliorated renal inflammation, oxidative stress, and fibrosis injury, all of which could comprise an effective strategy for the treatment of DN (Figure 8). This evidence concerns the gene AR and liver dysplastic nodule.